Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 18;10(12):e0145251.
doi: 10.1371/journal.pone.0145251. eCollection 2015.

A Functional Tricarboxylic Acid Cycle Operates during Growth of Bordetella pertussis on Amino Acid Mixtures as Sole Carbon Substrates

Affiliations

A Functional Tricarboxylic Acid Cycle Operates during Growth of Bordetella pertussis on Amino Acid Mixtures as Sole Carbon Substrates

Marie Izac et al. PLoS One. .

Abstract

It has been claimed that citrate synthase, aconitase and isocitrate dehydrogenase activities are non-functional in Bordetella pertussis and that this might explain why this bacterium's growth is sometimes associated with accumulation of polyhydroxybutyrate (PHB) and/or free fatty acids. However, the sequenced genome includes the entire citric acid pathway genes. Furthermore, these genes were expressed and the corresponding enzyme activities detected at high levels for the pathway when grown on a defined medium imitating the amino acid content of complex media often used for growth of this pathogenic microorganism. In addition, no significant PHB or fatty acids could be detected. Analysis of the carbon balance and stoichiometric flux analysis based on specific rates of amino acid consumption, and estimated biomass requirements coherent with the observed growth rate, clearly indicate that a fully functional tricarboxylic acid cycle operates in contrast to previous reports.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: This project was funded by a direct grant (MI) from Sanofi Pasteur, one of the international manufacturers of anti-Pertussis whole-cell and acellular vaccines. This grant was in the form of financial support for a collaborative research project including a PhD scholarship for MI. Sanofi Pasteur were involved in the study design and the decision to publish the data. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Kinetics of growth of B. pertussis Tohama I in batch cultures.
Results are displayed as mean values for the three biological replicates with a regular Y-scale (a) and a logarithmic Y-scale (b). Error bars represent the replicates' standard deviations. Dry cell weight concentrations have been calculated from OD measurements at 650 nm.
Fig 2
Fig 2. Kinetics of amino acid consumption of B. pertussis Tohama I in batches cultures.
(a): Kinetics of glutamate and proline; (b) kinetics of aromatic amino acids; (c): kinetics of amino acids derived from pyruvate; (d): kinetics of amino acids derived from oxaloacetate. Results are displayed as mean values for the three biological replicates and error bars represent standard deviations.
Fig 3
Fig 3. Estimation of carbon distribution within the central metabolic pathways based on the kinetic data from three biological replicates of B. pertussis Tohama I batch cultures.
(a) Growth period: 0–12h; (b) Growth period: 12h-end of culture. G6P: glucose-6-phosphate; F6P: fructose-6-phosphate; R5P: ribulose-5-phosphate; E4P: erythrose-4-phosphate; GAP: glyceraldehyde-3-phosphate; 3PG: 3-phosphoglycerate; PEP: phosphoenolpyruvate; PYR: pyruvate; AcCoA: acetyl-CoA; CIT: citrate, ISOC: isocitrate; αKG: α-ketoglutarate; SUC: succinate; MAL: malate; OAA: oxaloacetate; GLU: glutamate; PRO: proline; AA: amino acids; Phe: phenylalanine, Tyr: tyrosine; Ala: alanine; Gly: glycine; Ile: isoleucine; Leu: leucine; Ser: serine; Val: valine; Asp: aspartate; Lys: lysine; Met: methionine; Thr: threonine. Numerical data are reported for the three replicates as mean ± standard deviation. They are expressed in mmoles per liter and per gram of biomass (mM/gX).

References

    1. Edwards KM, Decker MD. 23—Pertussis vaccines In: Offit SAPAOA, editor. Vaccines (Sixth Edition) [Internet]. London: W.B. Saunders; 2013. [cited 2015 Jul 20]. p. 447–92. Available from: http://www.sciencedirect.com/science/article/pii/B9781455700905000306
    1. Ulloa-Gutierrez R. Pertussis vaccination in newborns. Expert Rev Vaccines. 2009. February;8(2):153–7. 10.1586/14760584.8.2.153 - DOI - PubMed
    1. Lambert LC. Pertussis vaccine trials in the 1990s. J Infect Dis. 2014. April 1;209 Suppl 1:S4–9. 10.1093/infdis/jit592 - DOI - PMC - PubMed
    1. Cherry JD. Epidemic Pertussis in 2012—The Resurgence of a Vaccine-Preventable Disease. N Engl J Med. 2012. August 30;367(9):785–7. 10.1056/NEJMp1209051 - DOI - PubMed
    1. He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008. June;3(3):329–39. 10.2217/17460913.3.3.329 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources